211 related articles for article (PubMed ID: 38201606)
1. Metastases and Recurrence Risk Factors in Endometrial Cancer-The Role of Selected Molecular Changes, Hormonal Factors, Diagnostic Methods and Surgery Procedures.
Markowska A; Baranowski W; Pityński K; Chudecka-Głaz A; Markowska J; Sawicki W
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201606
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound Measurement of Tumor-Free Distance from the Serosal Surface as the Alternative to Measuring the Depth of Myometrial Invasion in Predicting Lymph Node Metastases in Endometrial Cancer.
Liro M; Śniadecki M; Wycinka E; Wojtylak S; Brzeziński M; Stańczak A; Wydra D
Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441406
[TBL] [Abstract][Full Text] [Related]
3. Extended experience in the use of laparoscopic ultrasound to detect pelvic nodal metastasis in patients with cervical carcinoma.
Cheung TH; Lo WK; Yu MY; Yang WT; Ho S
Gynecol Oncol; 2004 Mar; 92(3):784-8. PubMed ID: 14984941
[TBL] [Abstract][Full Text] [Related]
4. An Extraordinary Location of Sentinel Lymph Nodes in a Patient with Endometrial Cancer.
Comba C; Aslan E; Vatankulu B; Tatar Z; Demir AA; Demir O
J Minim Invasive Gynecol; 2023 Aug; 30(8):613-614. PubMed ID: 37137423
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of Tumor-Free Distance and Other Alternative Ultrasound Biomarkers into a Myometrial Invasion-Based Model Better Predicts Lymph Node Metastasis in Endometrial Cancer: Evidence and Future Prospects.
Liro M; Śniadecki M; Wycinka E; Wojtylak S; Brzeziński M; Jastrzębska J; Wydra D
Diagnostics (Basel); 2022 Oct; 12(11):. PubMed ID: 36359447
[TBL] [Abstract][Full Text] [Related]
6. Port site metastases a year after initial laparoscopic cholecystectomy. Should the use of retrieval bags during laparoscopic cholecystectomy be the new gold standard?
Petryshyn N; Dražić T; Hogendorf P; Strzelczyk J; Strzałka A; Szwedziak K; Durczyński A
Pol Przegl Chir; 2021 May; 93(6):61-65. PubMed ID: 36169533
[TBL] [Abstract][Full Text] [Related]
7. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic hysteroscopy and the risk of malignant cells intraabdominal spread in women with endometrial cancer.
Stachowicz N; Mazurek D; Łoziński T; Czekierdowski A
Ginekol Pol; 2017; 88(10):562-567. PubMed ID: 29192417
[TBL] [Abstract][Full Text] [Related]
10. [Sentinel lymph node identification using hysteroscopy in patients with endometrial cancer].
Feranec R; Mouková L; Stanícek J; Stefániková L; Chovanec J
Klin Onkol; 2010; 23(2):92-8. PubMed ID: 20465087
[TBL] [Abstract][Full Text] [Related]
11. Predictors of extensive lymphatic dissemination and recurrences in node-positive endometrial cancer.
Zanfagnin V; Huang Y; Mc Gree ME; Weaver AL; Casarin J; Multinu F; Cappuccio S; Ferrero A; Mariani A; Glaser GE
Gynecol Oncol; 2019 Sep; 154(3):480-486. PubMed ID: 31324453
[TBL] [Abstract][Full Text] [Related]
12. [Use of hysteroscopy, ultrasonography and selected hormonal tests for diagnosis of hyperplastic endometrial changes].
Bedner R
Ann Acad Med Stetin; 2001; 47():89-105. PubMed ID: 12514904
[TBL] [Abstract][Full Text] [Related]
13. Is there any benefit of paraaortic field irradiation in pelvic lymph node positive endometrial cancer patients? A propensity match analysis.
Onal C; Yuce Sari S; Akkus Yildirim B; Gultekin M; Guler OC; Yildiz F
J Obstet Gynaecol; 2020 Oct; 40(7):1012-1019. PubMed ID: 31793400
[TBL] [Abstract][Full Text] [Related]
14. Management of the lymph nodes in penile cancer.
Heyns CF; Fleshner N; Sangar V; Schlenker B; Yuvaraja TB; van Poppel H
Urology; 2010 Aug; 76(2 Suppl 1):S43-57. PubMed ID: 20691885
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel subgroup of endometrial cancer patients with loss of thyroid hormone receptor beta expression and improved survival.
Piqué DG; Greally JM; Mar JC
BMC Cancer; 2020 Sep; 20(1):857. PubMed ID: 32894083
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic and prognostic value of lymphadenectomy in gynecological oncology].
Perzyło K; Miotła P; Lis E; Rechberger T
Ginekol Pol; 2013 Jul; 84(7):630-6. PubMed ID: 24032276
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-based risk model for preoperative prediction of lymph-node metastases in women with endometrial cancer: model-development study.
Eriksson LSE; Epstein E; Testa AC; Fischerova D; Valentin L; Sladkevicius P; Franchi D; Frühauf F; Fruscio R; Haak LA; Opolskiene G; Mascilini F; Alcazar JL; Van Holsbeke C; Chiappa V; Bourne T; Lindqvist PG; Van Calster B; Timmerman D; Verbakel JY; Van den Bosch T; Wynants L
Ultrasound Obstet Gynecol; 2020 Sep; 56(3):443-452. PubMed ID: 31840873
[TBL] [Abstract][Full Text] [Related]
18. Avoiding Full Lymphadenectomies in Intermediate- and High-Risk Endometrial Cancer by Sentinel Lymph Node Biopsy Implementation.
Pineda VG; Zapardiel I; Gracia M; Siegrist J; Diestro MD; Alonso M; Hernández A
Front Oncol; 2021; 11():654285. PubMed ID: 33937061
[TBL] [Abstract][Full Text] [Related]
19. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
20. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
Lax SF; Tamussino KF; Lang PF
Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
